Shares of CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) traded down 5.3% during mid-day trading on Monday . The stock traded as low as C$27.00 and last traded at C$27.00. 52,208 shares traded hands during trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Price Performance
The business’s 50 day moving average price is C$27.00.
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Read More
- Five stocks we like better than CanniMed Therapeutics
- Stock Market Upgrades: What Are They?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.